The abstract is read at the publisher; the summary is JClub's.
DriverDBv5 expands multi-omics cancer driver evaluation to 187 cohorts with 43,862 patients and 129,655 samples, enabling prognostic testing of driver genes.
- Why it matters: Multi-layer cancer alterations may carry outcome-relevant prognostic signals, but systematic assessment of multi-omics driver prognostic weight has been limited.
- What they did: The database integrates 154 non-TCGA cohorts using a generalized multi-omics barcode and supports Cox and mixture cure models plus machine learning on the full multi-omics feature matrix.
- The result: It provides tools to quantify prognostic effects, including joint effects across two omics layers, helping identify alterations linked to patient outcome.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.